Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNotes PayablesPayablesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Skinvisible (SKVI) Accumulated Expenses (2016 - 2026)

Skinvisible's Accumulated Expenses history spans 16 years, with the latest figure at $3.4 million for Q4 2025.

  • On a quarterly basis, Accumulated Expenses rose 20.55% to $3.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was $3.4 million, a 20.55% increase, with the full-year FY2025 number at $3.4 million, up 20.55% from a year prior.
  • Accumulated Expenses hit $3.4 million in Q4 2025 for Skinvisible, up from $3.2 million in the prior quarter.
  • Over the last five years, Accumulated Expenses for SKVI hit a ceiling of $3.4 million in Q4 2025 and a floor of $1.1 million in Q1 2021.
  • Historically, Accumulated Expenses has averaged $2.3 million across 5 years, with a median of $2.3 million in 2023.
  • Biggest five-year swings in Accumulated Expenses: surged 81.99% in 2021 and later grew 6.83% in 2025.
  • Tracing SKVI's Accumulated Expenses over 5 years: stood at $1.5 million in 2021, then soared by 32.59% to $2.0 million in 2022, then soared by 31.69% to $2.6 million in 2023, then grew by 8.13% to $2.8 million in 2024, then increased by 20.55% to $3.4 million in 2025.
  • Business Quant data shows Accumulated Expenses for SKVI at $3.4 million in Q4 2025, $3.2 million in Q3 2025, and $3.1 million in Q2 2025.